KIAA0226 (KIAA0226) (Middle Region) Peptid
KIAA0226
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Rubicon (KIAA0226) Produkte
- Rubicon (KIAA0226) (KIAA0226)
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- DQEGGGESQL SSVLRRSSFS EGQTLTVTSG AKKSHIRSHS DTSIASRGAP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-KIAA0226 Antibody(ARP58950_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Rubicon (KIAA0226) (KIAA0226)
- Hintergrund
-
KIAA0226 negatively regulates endocytic trafficking. KIAA0226 impairs the autophagosome maturation process.KIAA0226 may inhibit PIK3C3 activity.
Alias Symbols: RUBICON
Protein Interaction Partner: SMAD9,BECN1,PIK3C3,UVRAG
Protein Size: 927 - Molekulargewicht
- 103 kDa
- Gen-ID
- 9711
- NCBI Accession
- NM_001145642, NP_001139114
-
Sie sind hier:
